首页华领医药是一家立足中国，针对全球糖尿病患者尚未满足的临床需求，研发全球原创新药的生物技术公司。华领医药汇聚全球高端人才和科技资源，以国际顶级生物医药投资团队为依托，成功实现了全球首创糖尿病新药Dorzagliatin（HMS5552）在中国完成药品可开发性临床验证，率先进入注册性临床试验阶段。公司已在中国开展2个III期临床试验，分别针对新发未经治疗的和二甲双胍治疗失效的2型糖尿病患者人群。公司将启动药品生命周期管理相关临床试验，并拓展糖尿病个性化治疗和管理的先进理念，联合中国和美国糖尿病领域专家，实现对糖尿病和代谢性疾病及其并发症的有效控制。
Location: China, Shanghai
Total raised: $302.4M
Investors 5
| Date | Name | Website |
| 17.07.2021 | ARCH Ventu... | archventur... |
| - | F-Prime Ca... | fprimecapi... |
| - | Ally Bridg... | ally-bridg... |
| - | 6 Dimensio... | 6dimension... |
| - | Eight Road... | eightroads... |
Funding Rounds 4
| Date | Series | Amount | Investors |
| 19.09.2018 | IPO | $110M | - |
| 27.03.2018 | Series D | $117.4M | - |
| 22.04.2016 | Series C | $50M | - |
| 09.01.2015 | Series B | $25M | - |
Mentions in press and media 11
| Date | Title | Description | Source |
| 22.04.2021 | HUA MEDICINE (SHANGHAI) LTD. Hua Medicine Shanghai : Enviro... | (Incorporated in the Cayman Islands with limited liability) Stock Code: 2552 ENVIRONMENTAL, SOCIAL ... | marketscre... |
| 25.08.2020 | STAT China: Two more Hong Kong IPO filings, and Beijing’s la... | A version of this digest first appeared in the weekly STAT China newsletter. To receive future editi... | statnews.c... |
| 19.09.2018 | Ally Bridge Portfolio News – Hua Medicine Raises $110mn in H... | SEP 14, 2018 | BioCentury Diabetes company Hua Medicine Ltd. (HKSE:2552) raised HK$867 million ($11... | ally-bridg... |
| 27.03.2018 | Hua Medicine Raises $117.4 Million in Series D & Series ... | - | fprimecapi... |
| 27.03.2018 | Shanghai drugmaker Hua hauls in $117M megaround, with pla... | A diabetes drugmaker recently rumored to be planning a massive Hong Kong IPO has raised a $... | endpts.com... |
| 27.03.2018 | Ally Bridge Portfolio News – Hua Medicine Raises $117.4 Mill... | Hua Medicine, a clinical-stage drug development company developing novel therapies for the treatment... | ally-bridg... |
| 09.03.2018 | Term Sheet — Friday, March 9 | A TALE OF TWO COMPANIES Happy Friday, Term Sheet readers. Paid Content How can you protect what yo... | fortune.co... |
| 09.03.2018 | China’s Hua Medicine plans $400 million Hong Kong IPO, led b... | - | fprimecapi... |
| 25.04.2016 | Hua Medicine closes $50M round, looks to new diabetes target | China biotech Hua Medicine has raised $50 million in a Series C financing round as it looks to take ... | fiercebiot... |
| 22.04.2016 | Hua Medicine Raises $50M Series C Financing | Hua Medicine, a Shanghai, China-based clinical-stage company developing therapies, closed approx. $5... | finsmes.co... |
Show more